Covid Vulnerable Coronavirus Patients Getting At Home Treatment Which Improves Symptoms Within Hours Uk News

The health service has procured nearly five million doses of Pfizer Paxlovid and other antiviral drugs, such as Molnupiravir, through a government deal. Paxlovid has been found in trials to reduce hospital admissions and coronavirus deaths by 88% and has already been administered to more than 6,000 patients – 1,400 in the last seven days alone. Molnupiravir, which clinical trials indicate reduces the risk of hospitalization or death by 30%, was approved in November 2021 and has been used as a home remedy since December. Image: The health service said it had procured almost five million doses of Paxlovid. Photo: AP “I got back to work in four days” Helen West, 56, of Walderslade, Kent, received Paxlovid after testing positive for COVID and said she felt the difference in less than six hours. He had initially refused the drug, as “it did not feel very bad”. He added: “At first I felt good, a little tired, but two days later I had a very sore throat, to the point that I could not swallow or speak and could barely walk.” Ms. West has ankylosing spondylitis, a rare long-term condition in which the spine and other parts of the body become inflamed, painful and stiff, requiring her to take drugs that suppress her immune system. As her joints ached, she changed her mind and called the hospital to ask. “The process was so fast and efficient,” he said. “Within six hours of taking the first tablet, I felt a very small improvement. After four days, I returned to work. “COVID hit me hard, but Paxlovid really made a positive difference in my recovery.” Read more: Infections have leveled off and may have begun to fall, official figures show Spain tells unvaccinated UK tourists unacceptable Follow the Daily Podcast on Apple Podcasts, Google Podcasts, Spotify, Spreaker How are medicines administered – and are you eligible? The drugs are used to treat those who have been found to be at the highest risk of becoming seriously ill with COVID or being admitted to hospital, according to government guidelines. The treatment stops the virus from multiplying in the cells, helping patients fight the infection and get better, faster. They are currently only prescribed by clinicians on a case-by-case basis, but the health secretary says others may be eligible as part of a trial. Sajid Javid said: “Both of our pioneering antivirals – Molnupiravir and Paxlovid – are available to those most vulnerable to the virus directly through the NHS and it is fantastic to see 32,000 patients reap the benefits. “For anyone who does not belong to this high-risk group, if you are 50 years of age or older or 18 to 49 years old with an underlying health condition and the test is positive, you can enroll in the PANORAMIC study for possible access to this treatment.”

title: “Covid Vulnerable Coronavirus Patients Getting At Home Treatment Which Improves Symptoms Within Hours Uk News " ShowToc: true date: “2022-12-15” author: “Ruben Baumann”

The health service has procured nearly five million doses of Pfizer Paxlovid and other antiviral drugs, such as Molnupiravir, through a government deal. Paxlovid has been found in trials to reduce hospital admissions and coronavirus deaths by 88% and has already been administered to more than 6,000 patients – 1,400 in the last seven days alone. Molnupiravir, which clinical trials indicate reduces the risk of hospitalization or death by 30%, was approved in November 2021 and has been used as a home remedy since December. Image: The health service said it had procured almost five million doses of Paxlovid. Photo: AP “I got back to work in four days” Helen West, 56, of Walderslade, Kent, received Paxlovid after testing positive for COVID and said she felt the difference in less than six hours. He had initially refused the drug, as “it did not feel very bad”. He added: “At first I felt good, a little tired, but two days later I had a very sore throat, to the point that I could not swallow or speak and could barely walk.” Ms. West has ankylosing spondylitis, a rare long-term condition in which the spine and other parts of the body become inflamed, painful and stiff, requiring her to take drugs that suppress her immune system. As her joints ached, she changed her mind and called the hospital to ask. “The process was so fast and efficient,” he said. “Within six hours of taking the first tablet, I felt a very small improvement. After four days, I returned to work. “COVID hit me hard, but Paxlovid really made a positive difference in my recovery.” Read more: Infections have leveled off and may have begun to fall, official figures show Spain tells unvaccinated UK tourists unacceptable Follow the Daily Podcast on Apple Podcasts, Google Podcasts, Spotify, Spreaker How are medicines administered – and are you eligible? The drugs are used to treat those who have been found to be at the highest risk of becoming seriously ill with COVID or being admitted to hospital, according to government guidelines. The treatment stops the virus from multiplying in the cells, helping patients fight the infection and get better, faster. They are currently only prescribed by clinicians on a case-by-case basis, but the health secretary says others may be eligible as part of a trial. Sajid Javid said: “Both of our pioneering antivirals – Molnupiravir and Paxlovid – are available to those most vulnerable to the virus directly through the NHS and it is fantastic to see 32,000 patients reap the benefits. “For anyone who does not belong to this high-risk group, if you are 50 years of age or older or 18 to 49 years old with an underlying health condition and the test is positive, you can enroll in the PANORAMIC study for possible access to this treatment.”